Literature DB >> 1680620

Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.

F Berthou1, J P Flinois, D Ratanasavanh, P Beaune, C Riche, A Guillouzo.   

Abstract

Caffeine biotransformation and four monooxygenase activities involving cytochrome P-450IA2, namely ethoxy- and methoxyresorufin O-dealkylases, phenacetin O-deethylase, and acetanilide 4-hydroxylation were studied in 25 human liver microsomes. All these activities were highly significantly intercorrelated (r greater than 0.72, p less than 0.001) and correlated with the level of immunoreactive P-450IA2 content (r greater than 0.65; p less than 0.001). P-450IA content was measured by immunoblotting with anti-rat P-450 beta-naphthoflavone-B, an antibody that detects only a single band corresponding to P-450IA2. The formation rate of two caffeine metabolites, namely paraxathine and theobromine, was correlated with the four monooxygenase activities measured and P-450IA2-specific content (r greater than 0.75). However, inhibition studies of caffeine metabolism by phenacetin, a specific substrate of P-450IA2, clearly indicated that only the N-3 demethylation of caffeine was supported by this enzyme. These in vitro data demonstrate that P-450IA2 is predominantly responsible for the major metabolic pathway of caffeine and that the formation of other demethylated metabolites is mediated, at least partly, by other P-450 enzymes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680620

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  21 in total

1.  Biotransformation of caffeine by cDNA-expressed human cytochromes P-450.

Authors:  H R Ha; J Chen; S Krahenbuhl; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  A study on the route of 1-methylurate formation in theophylline metabolism.

Authors:  C Bayar; I Ozer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

3.  Removal of caffeine in sewage by Pseudomonas putida: Implications for water pollution index.

Authors:  O A Ogunseitan
Journal:  World J Microbiol Biotechnol       Date:  1996-05       Impact factor: 3.312

4.  Effect of caffeine concentration on biomass production, caffeine degradation, and morphology of Aspergillus tamarii.

Authors:  G Gutiérrez-Sánchez; S Roussos; C Augur
Journal:  Folia Microbiol (Praha)       Date:  2012-09-28       Impact factor: 2.099

Review 5.  Clinical pharmacokinetics of mexiletine.

Authors:  L Labbé; J Turgeon
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

6.  Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction.

Authors:  Duan Liu; Sisi Qin; Balmiki Ray; Krishna R Kalari; Liewei Wang; Richard M Weinshilboum
Journal:  Drug Metab Dispos       Date:  2018-07-06       Impact factor: 3.922

Review 7.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

8.  Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples.

Authors:  A Nordmark; S Lundgren; S Cnattingius; A Rane
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

9.  The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

Authors:  K T Batty; T M Davis; K F Ilett; L J Dusci; S R Langton
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

10.  Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.

Authors:  C Cazeneuve; G Pons; E Rey; J M Treluyer; T Cresteil; G Thiroux; P D'Athis; G Olive
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.